4Ma X,Does M,Raza A,et al.Myelodysplastic syndromes:incidence and survival in the United States[J].Cancer,2007,109(8):1536-42.
5Cheson BD,Bennett J M,Kantarjian H,et al.Report of an international working group to standardize response criteria for myelodysplastic syndromes[J].Blood,2000,96(12):3671-4.
6Thomas ML.Strategies for achieving transfusion independence in myelodysplastic syndromes[J].Eur J Oncol Nurs,2007,11(2):151-8.
7Kurtin S E,,Demakos E P.An update on the treatment of myelodysplastic syndromes. Clin J Oncol Nurs . 2010
8Demakos E P,Linebaugh J A.Advances in myelodysplastic syndrome:nursing implications of azacitidine. Clin J Oncol Nurs . 2005
9Thomas ML.Strategies for achieving transfusion independence in myelodysplastic syndromes. European Journal of Oncology Nursing . 2007
10Ma X,Does M,Raza A, et al.Myelodysplastic Syndromes:Incidence and Survival in the United States. Cancer . 2007
